Nanoparticle Formulation Market Size is valued at 5.87 billion in 2024 and is predicted to reach 13.74 billion by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034.
Nanoparticles are particles in the nanometer scale from 1 to 100 nm in diameter. These particles have proven helpful in many areas, including biomedicine, commonly for implants & drug delivery. Drug delivery with nanoparticles is an exciting field in which therapeutic compounds use nanoparticles as carriers to improve absorption, solubility, stability and decrease toxicity of the body.
Natural ingredients are back in fashion and useful because of their low toxicity and fewer side effects. However, natural compounds generally have low bioavailability and solubility, meaning the digestive system cannot readily absorb them. A feasible solution to these hitches is the usage of nanoparticles as drug delivery systems to act as delivery vehicles for therapeutics. Nanoparticles can provide many advantages for drug delivery, such as site-specific delivery and increased bioavailability. Additionally, nanoparticles aid in treating various disease conditions, including cancer, infectious diseases, cardiovascular disorders, and neurological disorders.
Due to the challenges related to process development, consistency of the constructs & reproducibility, biopharma companies started to opt for contract manufacturing services to save time and reduce the complexity of nanoparticle formulations.
Many research firms are seeking novel nanoparticle delivery technologies and focusing on more patient-centricity in drug development.
The Nanoparticle Formulation Market is categorized into type of nanoparticle formulated, type of organic nanoparticle formulated, type of inorganic nanoparticle formulated, and scale of operation. The type of nanoparticle formulated segment comprises organic nanoparticles, inorganic nanoparticles, and carbon-based nanoparticles. By type of organic nanoparticle formulated, the market is divided into polymeric nanoparticles, lipid nanoparticles, viral nanoparticles, protein-based nanoparticles, and other organic nanoparticles.
The type of inorganic nanoparticle formulated segment consists of metal nanoparticles, quantum dots, silica nanoparticles, magnetic nanoparticles, and other inorganic nanoparticles. Based on the scale of operation, the market is segmented into preclinical, clinical, and commercial.
Due to several advantages of lipid nanoparticles in therapeutics, pharma companies are collaborating with industries specializing in lipid nanoparticle formulation to expand their capabilities and improve product quality. In September 2022, NeoVac and Aragen Life Sciences Private Limited announced an agreement to create a lipid product that will enable the development of lipid nanoparticles (LNP) for use in producing RNA vaccines for various diseases. In 2021, WACKER collaborated with CordenPharma. Both companies reported that they intend to jointly develop novel methods for manufacturing Lipid Nanoparticles (LNPs) to meet the growing market demand.
The clinical category is expected to retain a significant share of the nanoparticle formulation market over the forecast period. Many ongoing clinical studies on drug therapies and vaccines for treating various diseases, including cancer, cardiovascular diseases (CVDs), and infectious diseases, are expanding the clinical segment of the market.
Factors such as the surging demand for targeted therapies, innovations in nanoparticle delivery systems, and increasing research efforts in drug development technologies are responsible for the blooming of the nanoparticle formulation market in North America, followed by Europe. At the same time, the Asia Pacific regional market is predicted to witness steady growth in the next few years. Increasing inventions, the introduction of nanoparticle delivery systems, and growing chronic diseases will likely drive the nanoparticle formulation market in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 5.87 Bn |
|
Revenue Forecast In 2034 |
USD 13.74 Bn |
|
Growth Rate CAGR |
CAGR of 9.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type of Nanoparticle Formulated, By Type of Organic Nanoparticle Formulated, By Type of Inorganic Nanoparticle Formulated, By Scale of Operation |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Ascension Sciences, DIANT Pharma, ExonanoRNA, Nanoform, NanoVation Therapeutics, NanoVelos, NTT Biopharma, Organoid-X BioTech, Vaxinano, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanoparticle Formulation Market Snapshot
Chapter 4. Global Nanoparticle Formulation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Nanoparticle Formulated Estimates & Trend Analysis
5.1. by Type of Nanoparticle Formulated & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Nanoparticle Formulated:
5.2.1. Organic Nanoparticles
5.2.2. Inorganic Nanoparticles
5.2.3. Carbon-based Nanoparticles
Chapter 6. Market Segmentation 2: by Type of Organic Nanoparticle Formulated Estimates & Trend Analysis
6.1. by Type of Organic Nanoparticle Formulated & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Organic Nanoparticle Formulated:
6.2.1. Polymeric Nanoparticles
6.2.2. Lipid Nanoparticles
6.2.3. Viral Nanoparticles
6.2.4. Protein-based Nanoparticles
6.2.5. Other Organic Nanoparticles
Chapter 7. Market Segmentation 3: by Type of Inorganic Nanoparticle Formulated Estimates & Trend Analysis
7.1. by Type of Inorganic Nanoparticle Formulated & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Inorganic Nanoparticle Formulated:
7.2.1. Metal Nanoparticles
7.2.2. Quantum Dots
7.2.3. Silica Nanoparticles
7.2.4. Magnetic Nanoparticles
7.2.5. Other Inorganic Nanoparticles
Chapter 8. Market Segmentation 4: by Scale of Operation Estimates & Trend Analysis
8.1. by Scale of Operation & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Scale of Operation:
8.2.1. Preclinical
8.2.2. Clinical
8.2.3. Commercial
Chapter 9. Nanoparticle Formulation Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticle Formulated, 2021-2034
9.1.2. North America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Organic Nanoparticle Formulated, 2021-2034
9.1.3. North America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Inorganic Nanoparticle Formulated, 2021-2034
9.1.4. North America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.1.5. North America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticle Formulated, 2021-2034
9.2.2. Europe Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Organic Nanoparticle Formulated, 2021-2034
9.2.3. Europe Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Inorganic Nanoparticle Formulated, 2021-2034
9.2.4. Europe Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.2.5. Europe Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticle Formulated, 2021-2034
9.3.2. Asia Pacific Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Organic Nanoparticle Formulated, 2021-2034
9.3.3. Asia-Pacific Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Inorganic Nanoparticle Formulated, 2021-2034
9.3.4. Asia-Pacific Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.3.5. Asia Pacific Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticle Formulated, 2021-2034
9.4.2. Latin America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Organic Nanoparticle Formulated, 2021-2034
9.4.3. Latin America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Inorganic Nanoparticle Formulated, 2021-2034
9.4.4. Latin America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.4.5. Latin America Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticle Formulated, 2021-2034
9.5.2. Middle East & Africa Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Organic Nanoparticle Formulated, 2021-2034
9.5.3. Middle East & Africa Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Inorganic Nanoparticle Formulated, 2021-2034
9.5.4. Middle East & Africa Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.5.5. Middle East & Africa Nanoparticle Formulation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Ascension Sciences
10.2.2. DIANT Pharma
10.2.3. ExonanoRNA
10.2.4. Nanoform
10.2.5. NanoVation Therapeutics
10.2.6. NanoVelos
10.2.7. NTT Biopharma
10.2.8. Organoid-X BioTech
10.2.9. Vaxinano
10.2.10. Other Prominent Players
Nanoparticle Formulation Market By Type of Nanoparticle Formulated-
Nanoparticle Formulation Market By Type of Organic Nanoparticle Formulated-
Nanoparticle Formulation Market By Type of Inorganic Nanoparticle Formulated-
Nanoparticle Formulation Market By Scale of Operation-
Nanoparticle Formulation Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
